Found: 29
Select item for more details and to access through your institution.
How donanemab data address the coverage with evidence development questions.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 4, p. 3127, doi. 10.1002/alz.13700
- By:
- Publication type:
- Article
Donanemab in Early Symptomatic Alzheimer's Disease: Efficacy and Safety in TRAILBLAZER‐ALZ 2, a Phase 3 Randomized Clinical Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082733
- By:
- Publication type:
- Article
Incremental declines in independence associated with disease progression in early symptomatic Alzheimer's disease (AD).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082395
- By:
- Publication type:
- Article
Demonstration of the iADRS as an integrated measure of global disease severity in early symptomatic Alzheimer's disease using Rasch measurement theory (RMT).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082362
- By:
- Publication type:
- Article
Distinct associations between tau PET and cognitive impairment across brain regions and cognitive domains in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078345
- By:
- Publication type:
- Article
Disease progression model using the integrated Alzheimer's Disease Rating Scale.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 6, p. 2253, doi. 10.1002/alz.12876
- By:
- Publication type:
- Article
Reasons for study exclusion by sex in lanabecestat studies AMARANTH and DAYBREAK‐ALZ: Human/Human trials: Other.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038663
- By:
- Publication type:
- Article
Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1483, doi. 10.1002/alz.12164
- By:
- Publication type:
- Article
Clinical meaningfulness addressed at Alzheimer's Association Research Roundtable.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 5, p. 814, doi. 10.1002/alz.12111
- By:
- Publication type:
- Article
FTS3‐01‐03: PERFORMANCE ON EXPLORATORY EFFICACY VARIABLES IN AMARANTH, A RANDOMIZED PHASE 2/3 STUDY IN EARLY ALZHEIMER'S DISEASE WITH LANABECESTAT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P873, doi. 10.1016/j.jalz.2019.06.4620
- By:
- Publication type:
- Article
FTS3‐01‐02: SUBGROUP POPULATIONS IN AMARANTH, A RANDOMIZED PHASE 2/3 STUDY IN EARLY ALZHEIMER'S DISEASE WITH LANABECESTAT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P872, doi. 10.1016/j.jalz.2019.06.4619
- By:
- Publication type:
- Article
DT‐01‐04: LANABECESTAT: BASELINE CHARACTERISTICS OF PARTICIPANTS RANDOMIZED IN THE PHASE 2/3 AMARANTH STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1666, doi. 10.1016/j.jalz.2018.07.006
- By:
- Publication type:
- Article
P4‐341: THE COMPUTERIZED COGNITIVE COMPOSITE (C3) AND AMYLOID STATUS AMONG NORMAL OLDER ADULTS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1597, doi. 10.1016/j.jalz.2018.07.164
- By:
- Publication type:
- Article
P4‐210: LANABECESTAT: SCREENING PERFORMANCE FROM THE AMARANTH STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1521, doi. 10.1016/j.jalz.2018.07.031
- By:
- Publication type:
- Article
THE INTEGRATED ALZHEIMER’S DISEASE RATING SCALE (IADRS): FINDINGS FROM THE EXPEDITION3 TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1521, doi. 10.1016/j.jalz.2017.07.649
- By:
- Publication type:
- Article
Diabetes and cognitive decline in elderly African Americans: A 15-year follow-up study
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2011, v. 7, n. 4, p. 418, doi. 10.1016/j.jalz.2010.07.003
- By:
- Publication type:
- Article
P2-077: Comparison of manual and automated determination of hippocampal volumes in MCI and older adults with cognitive complaints
- Published in:
- 2008
- By:
- Publication type:
- Abstract
IC-P1-054: Comparison of manual and automated determination of hippocampal volumes in MCI and older adults with cognitive complaints
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 6, p. 512, doi. 10.1001/jama.2023.13239
- By:
- Publication type:
- Article
Differential impact of subclinical carotid artery disease on cerebral structure and functioning in type 1 diabetes patients with versus those without proliferative retinopathy.
- Published in:
- Cardiovascular Diabetology, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1475-2840-13-58
- By:
- Publication type:
- Article
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 2, p. 199, doi. 10.1001/jamaneurol.2019.3988
- By:
- Publication type:
- Article
Population Pharmacokinetic Modeling of Ziprasidone in Patients With Schizophrenia From the CATIE Study.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
Cognitive Performance in Type 1 Diabetes Patients Is Associated with Cerebral White Matter Volume.
- Published in:
- Diabetes, 2007, v. 56, p. A1
- By:
- Publication type:
- Article
Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Microvascular Disease in Type 1 Diabetes Alters Brain Activation.
- Published in:
- Diabetes, 2006, v. 55, n. 2, p. 334, doi. 10.2337/diabetes.55.02.06.db05-0680
- By:
- Publication type:
- Article
Integrated Alzheimer's Disease Rating Scale: Clinically meaningful change estimates.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022, v. 8, n. 1, p. 1, doi. 10.1002/trc2.12312
- By:
- Publication type:
- Article
Building clinically relevant outcomes across the Alzheimer’s disease spectrum.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2021, v. 7, n. 1, p. 1, doi. 10.1002/trc2.12181
- By:
- Publication type:
- Article
Lanabecestat: Neuroimaging results in early symptomatic Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2021, v. 7, n. 1, p. 1, doi. 10.1002/trc2.12123
- By:
- Publication type:
- Article
Cytochrome P450 Polymorphisms and their Relationship with Premature Ovarian Failure in Premenopausal Women with Breast Cancer Receiving Doxorubicin and Cyclophosphamide.
- Published in:
- Breast Journal, 2011, v. 17, n. 5, p. 536, doi. 10.1111/j.1524-4741.2011.01144.x
- By:
- Publication type:
- Article